IP Library › Granted Patent US 12,746,338
Granted Patent B2
US 12,746,338 · App. 17/926,157 · Granted Sep 29, 2026

Management platform for intelligent injection devices

Inventors: Jeremy Corbett (Nicholasville, KY); John Spencer (Lexington, KY); Nathaniel Mitchell (Nicholasville, KY)
Assignee: DataDose, LLC
A61M5/31501A61M5/31568G16H10/60G16H20/17G16H40/20A61M2205/3368A61M2205/3584A61M2205/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,746,338
App. No.
17/926,157
Granted
Sep 29, 2026
Kind
B2
Abstract

A reporting injection device, including a barrel in fluid communication with a needle connected with a first end of the barrel, a piston including a plunger, the piston positioned within a second end of the barrel and the plunger having a fluid-tight interaction with an interior of the barrel, and a microprocessor in electronic communication with a switch and a wireless module, the microprocessor configured to send an administration data from the wireless module after triggering the switch.

Claims (24)

1 . An intelligent injection device for injection of a pharmaceutical into a patient, the intelligent injection device comprising:

a barrel having an interior for holding a pharmaceutical, the barrel further having a first end and a second end;

a needle in fluid communication with the barrel and connected with the first end of the barrel;

a piston positioned within the second end of the barrel, the piston including a plunger having a fluid-tight interaction with the interior of the barrel;

a mechanical switch disposed on the piston and configured to close upon completion of injection of said pharmaceutical into said patient;

a wireless module configured to transmit administration data related to injection of said pharmaceutical from the intelligent injection device, wherein the wireless module is coupled to the intelligent injection device;

a microprocessor in electrical communication with the mechanical switch and the wireless module, wherein the microprocessor is configured to transmit the administration data related to injection of said pharmaceutical via the wireless module in response to completion of the injection of said pharmaceutical into said patient resulting in closing of the mechanical switch;

a temperature sensor in electrical communication with the microprocessor and configured to sense a temperature of said pharmaceutical and transmit temperature data to the microprocessor indicative of the temperature of said pharmaceutical; and

a locking mechanism engaged with the piston and in electrical communication with the microprocessor, wherein the microprocessor is configured to transmit a locking signal to the locking mechanism, and the locking mechanism is configured to lock the piston in response to receiving the locking signal in response to a degradation risk, determined by the microprocessor, correlating to said pharmaceutical being above a predetermined threshold.

2 . The intelligent injection device of claim 1 , further comprising a load sensor in electrical communication with the microprocessor and configured to sense force caused by depression of the plunger and transmit force data to the microprocessor indicative of the force caused by the depression of the plunger.

3 . The intelligent injection device of claim 1 , further comprising an amount sensor in electrical communication with the microprocessor and configured to sense an amount of said pharmaceutical injected into said patient upon depression of the plunger and transmit pharmaceutical amount data to the microprocessor indicative of said amount of said pharmaceutical injected into said patient upon the depression of the plunger.

4 . The intelligent injection device of claim 1 , further comprising a damage sensor in electrical communication with the microprocessor and configured to sense damage to the intelligent injection device and transmit damage data to the microprocessor indicative of the damage to the intelligent injection device.

5 . The intelligent injection device of claim 1 , further comprising an automatic injection system configured to facilitate automatic delivery of said pharmaceutical by the intelligent injection device into said patient.

6 . The intelligent injection device of claim 1 , further comprising an injectable administration compliance management platform configured to operate an Internet of Things-based system at least partially implemented in the microprocessor of the intelligent injection device.

7 . The intelligent injection device of claim 6 , wherein the injectable administration compliance management platform is configured for real-time monitoring of the intelligent injection device and management of adherence to an injectable administration plan.

8 . The intelligent injection device of claim 1 , further comprising an injectable administration compliance management platform configured to receive data collected by at least one Internet of Things device and combine with data collected by the intelligent injection device.

9 . The intelligent injection device of claim 1 , further comprising an injectable administration compliance management platform configured to receive data collected by at least one Internet of Things device and at least one wearable device and combine with data collected by the intelligent injection device.

10 . The intelligent injection device of claim 1 , further comprising an injectable administration compliance management platform configured to receive medical compliance data and combine with data collected by the intelligent injection device.

11 . The intelligent injection device of claim 1 , further comprising an injectable administration compliance management platform configured to receive at least one of an artificial intelligence datum, artificial intelligence model or machine learning model and combine with data collected by the intelligent injection device.

12 . The intelligent injection device of claim 1 , further comprising an injectable administration compliance management platform configured to receive at least one of electronic medical record data or emergency health record data and combine with data collected by the intelligent injection device.

13 . The intelligent injection device of claim 1 , further comprising an injectable administration compliance management platform configured to operate an intelligent virtual care assistant module to perform a task for a person associated with a usage of the intelligent injection device.

14 . The intelligent injection device of claim 13 , wherein the intelligent virtual care assistant module displays an alert to the person associated with the usage of the intelligent injection device.

15 . The intelligent injection device of claim 13 , wherein the intelligent virtual care assistant module is configured to present a virtual reality display to the person using the intelligent injection device.

16 . The intelligent injection device of claim 13 , wherein the intelligent virtual care assistant module is configured to present an augmented reality display to one of the person and the patient using the intelligent injection device.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2022
From: CORBETT, JEREMY; SPENCER, JOHN; MITCHELL, NATHANIEL
To: DATADOSE, LLC
Reel/Frame 061842/0944 →
Continuity (2)
Provisional Application 63028182 · May 21, 2020
Related Publication 20230191036A1 · Jun 22, 2023
References Cited (170)
US 4950246A · Muller · 1990 [cited by applicant]
US 7300418B2 · Zaleski · 2007 [cited by applicant]
US 9317916B1 · Hanina et al. · 2016 [cited by applicant]
US 9623191B2 · Uber et al. · 2017 [cited by applicant]
US 10825560B1 · Berenson · 2020 [cited by applicant]
US 10911515B2 · Biasi et al. · 2021 [cited by applicant]
US 11102304B1 · Jain et al. · 2021 [cited by applicant]
US 11210611B2 · Kamen et al. · 2021 [cited by applicant]
US 12260959B1 · Minetti et al. · 2025 [cited by applicant]
US 20010047281A1 · Keresman, III et al. · 2001 [cited by applicant]
US 20030036683A1 · Kehr et al. · 2003 [cited by applicant]
US 20030110060A1 · Clementi · 2003 [cited by applicant]
US 20070179453A1 · Lim et al. · 2007 [cited by applicant]
US 20070219503A1 · Loop et al. · 2007 [cited by applicant]
US 20070225653A1 · Lim et al. · 2007 [cited by applicant]
US 20090076338A1 · Zdeblick et al. · 2009 [cited by applicant]
US 20110009812A1 · Brown · 2011 [cited by applicant]
US 20120209243A1 · Yan · 2012 [cited by applicant]
US 20130023813A1 · Roorda · 2013 [cited by applicant]
US 20130023825A1 · Edwards · 2013 [cited by examiner]
US 20130276785A1 · Melker et al. · 2013 [cited by applicant]
US 20130310756A1 · Whalley · 2013 [cited by examiner]
US 20130338628A1 · Robertson et al. · 2013 [cited by applicant]
US 20140074454A1 · Brown et al. · 2014 [cited by applicant]
US 20140180711A1 · Kamen et al. · 2014 [cited by applicant]
US 20140207099A1 · Nagar et al. · 2014 [cited by applicant]
US 20150057611A1 · Bureau · 2015 [cited by applicant]
US 20150112703A1 · Sysko · 2015 [cited by examiner]
US 20150174342A1 · Mitrosky et al. · 2015 [cited by applicant]
US 20150278924A1 · Maurer et al. · 2015 [cited by applicant]
US 20160012205A1 · Saint · 2016 [cited by examiner]
US 20160042154A1 · Goldberg et al. · 2016 [cited by applicant]
US 20160171597A1 · Todeschini · 2016 [cited by applicant]
US 20160171777A1 · Todeschini et al. · 2016 [cited by applicant]
US 20160243318A1 · Despa et al. · 2016 [cited by applicant]
US 20160259913A1 · Yu et al. · 2016 [cited by applicant]
US 20170007765A1 · Cowe · 2017 [cited by examiner]
US 20170076060A1 · Pilkington et al. · 2017 [cited by applicant]
US 20170095638A1 · Young et al. · 2017 [cited by applicant]
US 20170119969A1 · McCullough et al. · 2017 [cited by applicant]
US 20170136185A1 · Rios et al. · 2017 [cited by applicant]
US 20170146381A1 · Eckel et al. · 2017 [cited by applicant]
US 20170203030A1 · Brewer et al. · 2017 [cited by applicant]
US 20170245943A1 · Foster et al. · 2017 [cited by applicant]
US 20170262604A1 · Francois · 2017 [cited by applicant]
US 20170325091A1 · Freeman et al. · 2017 [cited by applicant]
US 20170357775A1 · Ekin · 2017 [cited by applicant]
US 20180017531A1 · Juhnke · 2018 [cited by examiner]
US 20180085517A1 · Laurence et al. · 2018 [cited by applicant]
US 20180113985A1 · Gandy et al. · 2018 [cited by applicant]
US 20180133400A1 · Almoumen · 2018 [cited by applicant]
US 20180166163A1 · Sudharsan · 2018 [cited by applicant]
US 20180182491A1 · Belliveau et al. · 2018 [cited by applicant]
US 20180193564A1 · Dahmani · 2018 [cited by applicant]
US 20180308569A1 · Luellen · 2018 [cited by applicant]
US 20180333543A1 · Diaz et al. · 2018 [cited by applicant]
US 20180369488A1 · Carlsson et al. · 2018 [cited by applicant]
US 20190054247A1 · Dantsker · 2019 [cited by examiner]
US 20190060577A1 · Vallis · 2019 [cited by examiner]
US 20190130792A1 · Rios et al. · 2019 [cited by applicant]
US 20190209777A1 · O'Connell · 2019 [cited by examiner]
US 20190247050A1 · Goldsmith · 2019 [cited by applicant]
US 20190262534A1 · Agard et al. · 2019 [cited by applicant]
US 20190282761A1 · Wilson et al. · 2019 [cited by applicant]
US 20200016331A1 · Lee · 2020 [cited by examiner]
US 20200061301A1 · Hatamian et al. · 2020 [cited by applicant]
US 20200082327A1 · Arefieg · 2020 [cited by applicant]
US 20200086046A1 · Corbett et al. · 2020 [cited by applicant]
US 20200093993A1 · O'Rourke et al. · 2020 [cited by applicant]
US 20200139053A1 · Faught · 2020 [cited by examiner]
US 20200226951A1 · Rios et al. · 2020 [cited by applicant]
US 20200289751A1 · Despa et al. · 2020 [cited by applicant]
US 20200303047A1 · Bostic et al. · 2020 [cited by applicant]
US 20200350052A1 · Saint et al. · 2020 [cited by applicant]
US 20200364801A1 · Basra · 2020 [cited by applicant]
US 20200390596A1 · Chalberg, Jr. et al. · 2020 [cited by applicant]
US 20210008294A1 · Gentz · 2021 [cited by applicant]
US 20210060246A1 · Weydt et al. · 2021 [cited by applicant]
US 20210217516A1 · Nash et al. · 2021 [cited by applicant]
US 20210260289A1 · Kamath et al. · 2021 [cited by applicant]
US 20210288950A1 · Rodriguez Bravo et al. · 2021 [cited by applicant]
US 20220023391A1 · Michelich et al. · 2022 [cited by applicant]
US 20220031956A1 · Helmer · 2022 [cited by applicant]
US 20220051778A1 · Kühni et al. · 2022 [cited by applicant]
US 20220183915A1 · Augustine et al. · 2022 [cited by applicant]
US 20220301681A1 · Coetzee · 2022 [cited by applicant]
US 20220336074A1 · Bakos et al. · 2022 [cited by applicant]
US 20230081577A1 · Walker et al. · 2023 [cited by applicant]
US 20230191036A1 · Corbett et al. · 2023 [cited by applicant]
US 20230298723A1 · Mercolino et al. · 2023 [cited by applicant]
US 20230302224A1 · Prince et al. · 2023 [cited by applicant]
US 20230330328A1 · Moberg et al. · 2023 [cited by applicant]
US 20230368226A1 · Mestres et al. · 2023 [cited by applicant]
US 20230386677A1 · Ferro et al. · 2023 [cited by applicant]
US 20230414432A1 · Augustine et al. · 2023 [cited by applicant]
US 20230414433A1 · Augustine et al. · 2023 [cited by applicant]
US 20240157045A1 · Kostal et al. · 2024 [cited by applicant]
US 20240232031A1 · Kang et al. · 2024 [cited by applicant]
US 20240285956A1 · Forsell · 2024 [cited by applicant]
US 20250000453A1 · Lettman et al. · 2025 [cited by applicant]
US 20250050014A1 · Shin et al. · 2025 [cited by applicant]
US 20250054615A1 · Ronen et al. · 2025 [cited by applicant]
US 20250329451A1 · Minetti et al. · 2025 [cited by applicant]
US 20260079511A1 · Roychoudhury et al. · 2026 [cited by applicant]
CA 3140408A1 · 2020 [cited by applicant]
EP 3991771A1 · 2022 [cited by applicant]
WO 2006060572A1 · 2006 [cited by applicant]
WO 2016210404A1 · 2016 [cited by applicant]
WO 2017156523A1 · 2017 [cited by applicant]
WO 2018009509A2 · 2018 [cited by applicant]
WO 2018106475A1 · 2018 [cited by applicant]
WO 2020236481A1 · 2020 [cited by applicant]
WO 2021237085A1 · 2021 [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/131,749, dated Apr. 1, 2020, 9 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 16/131,749, dated Oct. 1, 2020, 11 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/131,749, dated Mar. 2, 2021, 13 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/131,749, dated Sep. 16, 2021, 10 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/131,749, dated Jan. 13, 2022, 7 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/724,177, dated Apr. 11, 2024, 11 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 17/724,177, dated Oct. 22, 2024, 13 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/724,177 dated Apr. 21, 2025, 9 pages. [cited by applicant]
Restriction Requirement Office Action for U.S. Appl. No. 19/031,780 dated May 19, 2025, 6 pages. [cited by applicant]
Restriction Requirement Office Action for U.S. Appl. No. 19/031,836 dated Apr. 25, 2025, 6 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 19/031,836 dated Jul. 18, 2025, 17 pages. [cited by applicant]
Restriction Requirement Office Action for U.S. Appl. No. 19/031,854 dated May 9, 2025, 6 pages. [cited by applicant]
Restriction Requirement Office Action for U.S. Appl. No. 19/031,862 dated May 9, 2025, 6 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 19/031,940 dated Apr. 11, 2025, 25 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 19/031,940 dated Jul. 3, 2025, 13 pages. [cited by applicant]
Examination Report dated Nov. 17, 2025 for European Application No. 21808546.2, 5 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 19/031,836 dated Nov. 26, 2025, 26 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 19/280,969 dated Dec. 1, 2025, 38 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 19/281,013 dated Dec. 11, 2025, 35 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 19/281,035 dated Dec. 11, 2025, 29 pages. [cited by applicant]
International Search Report and Written Opinion of International Searching Authority with mailing dates of Oct. 20, 2021 for International Application No. PCT/US2021/033646. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/031,854 dated Jul. 28, 2025, 32 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/031,862 dated Jul. 29, 2025, 43 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 19/031,780 dated Aug. 6, 2025, 30 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/031,940 dated Oct. 17, 2025, 21 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 17/724,177, dated Oct. 29, 2025, 32 pages. [cited by applicant]
Extended European Search Report dated May 23, 2024 for European Application No. 21808546.2. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/031,780 dated Dec. 29, 2025, 20 pages. [cited by applicant]
Non-Final Office Action or U.S. Appl. No. 19/314,966 dated Dec. 31, 2025, 42 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/315,011 dated Jan. 7, 2026, 39 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/314,936 dated Jan. 13, 2026, 30 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/724,177 dated Jan. 13, 2026, 12 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/031,881 dated Jan. 14, 2026, 49 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/315,027 dated Feb. 6, 2026, 37 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/031,780 dated Feb. 27, 2026, 26 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 19/280,969 dated Mar. 4, 2026, 38 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/724,177 dated Mar. 10, 2026, 25 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 19/031,870 dated Mar. 25, 2026, 52 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/314,864 dated Mar. 27, 2026, 45 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 19/281,013 dated Mar. 30, 2026, 29 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 19/281,035 dated Mar. 30, 2026, 32 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 19/031,928 dated Apr. 7, 2026, 53 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/315,011 dated Apr. 7, 2026, 15 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/031,940 dated Apr. 8, 2026, 28 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/724,177 dated Apr. 9, 2026, 16 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/031,780 dated Apr. 9, 2026, 17 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/314,936 dated Apr. 10, 2026, 15 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/031,881 dated Apr. 15, 2026, 22 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/031,836 dated Apr. 17, 2026, 23 pages. [cited by applicant]
Mahzabin, Rahnuma et al. “Blockchain associated machine learning and loT based hypoglycemia detection system with auto-injection feature”, Indonesian Journal of Electrical Engineering and Computer Science, vol. 27, No. … [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 19/031,911 dated Apr. 20, 2026, 55 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 19/314,966 dated Apr. 20, 2026, 24 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 19/031,890 dated Apr. 21, 2026, 53 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/451,171 dated Apr. 22, 2026, 37 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/451,472 mailed May 13, 2026, 48 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2025/053140 mailed Jun. 10, 2026, 39 pages. [cited by applicant]
Faisal S, Samoth D, Aslam Y, Patel H, Park S, Baby B, Patel T. Key Features of Smart Medication Adherence Products: Updated Scoping Review. JMIR Aging. Dec. 19, 2023;6:e50990. doi: 10.2196/50990. PMID: 38113067; PMCID: … [cited by applicant]